Bullish
Sector Gamma AS increased its holdings in Edwards Lifesciences Corporation (NYSE:EW) by 32.1% in the recent quarter, acquiring an additional 23,422 sh...
Neutral
BLI Banque de Luxembourg Investments purchased a new position in shares of Edwards Lifesciences Corporation (NYSE:EW – Free Report) in the 4th quarter...
Neutral
Edwards Lifesciences (NYSE:EW) recently hit a new 52-week high of $89.48, closing at $87.45. The company reported strong Q1 earnings, beating estimate...
Neutral
Norges Bank acquired a new stake in Edwards Lifesciences Corporation (NYSE:EW – Free Report) in the fourth quarter, HoldingsChannel reports. The firm ...
Neutral
Andrew Dahl, Senior Vice President at Edwards Lifesciences Corp, sold 568 shares of the company on May 29, 2026, reducing his total holdings to 15,334...
Bullish
Edwards Lifesciences Corp. (EW) has reached a new 52-week high of USD 87.93, highlighting its strong position in the Pharmaceuticals & Biotechnology s...
Bullish
Legal & General Group Plc increased its stake in Edwards Lifesciences Corporation (EW) by 7.5% in the fourth quarter, holding 4.42 million shares valu...
Neutral
Swedbank AB decreased its stake in Edwards Lifesciences (NYSE:EW) by 38.5% in the fourth quarter of 2025, selling 192,442 shares and retaining 307,563...
Neutral
Rathbones Group PLC significantly decreased its stake in Edwards Lifesciences (NYSE:EW) by 81% in the fourth quarter, selling 71,276 shares and retain...